The report "Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Plasmid DNA, microRNA), Sample Type (Cellular, FFPE, CfDNA/CtDNA), Application, End User, Competition - Global Forecast to 2031" is projected to reach USD 9.66 billion by 2031 from USD 6.37 billion in 2026, at a CAGR of 8.7% during the forecast period.
Browse 670 market data Tables and 55 Figures spread through 548 Pages and in-depth TOC on "Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Plasmid DNA, microRNA), Sample Type (Cellular, FFPE, CfDNA/CtDNA), Application, End User, Competition - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/nucleic-acid-isolation-purification-market-229978287.html
In recent years, the nucleic acid isolation and purification (NAIP) market has grown significantly, supported by rising investments in molecular diagnostics, genomics, precision medicine, and biopharmaceutical research. NAIP technologies are now widely used across infectious disease testing, oncology diagnostics, genetic testing, drug discovery, liquid biopsy, and academic research, with high-quality DNA and RNA extraction serving as a critical first step for downstream applications such as PCR, qPCR, and next-generation sequencing.
The kits segment accounted for the largest share of the global nucleic acid isolation and purification market, by product, in 2025.
The global nucleic acid isolation and purification market is segmented by products into kits, reagents, and instruments. The instruments segment is further segmented into automatic and manual instruments. In 2025, the kits segment accounted for the largest share of the global nucleic acid isolation and purification market. Factors driving the market growth include the benefits of kits, such as price and ease of usage in molecular biology techniques.
The personalized medicine application segment is expected to be the fastest-growing during the forecast period.
The global nucleic acid isolation and purification market is segmented by application into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications. In 2025, the personalized medicine application was the fastest-growing segment of the global nucleic acid isolation and purification market. This dominance stems from the rising adoption of NGS-based clinical testing and biomarker-driven treatment selection. Personalized medicine workflows require reproducible and standardized sample preparation to ensure reliable genomic profiling results. This is pushing hospitals, reference labs, and biopharma companies to adopt more advanced NAIP solutions that support low-input recovery, automation, traceability, and regulatory-ready workflows, making personalized medicine one of the strongest growth application areas for the NAIP market.
North America accounted for the largest regional share of the global nucleic acid isolation and purification market in 2025.
North America accounted for the largest share of regional revenues and is the primary engine of growth. The growth in the North American nucleic acid isolation and purification market is driven by increasing public-private investments in the life science industry, rising awareness of DNA testing technology and its application among disease diagnostics, growing technological advancements in instruments, and the presence of major market players in the region, coupled with the growing commercialization of isolation and purification products.
Key Players
Key players in the nucleic acid isolation and purification market include Thermo Fisher Scientific Inc. (US), Qiagen N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Merck KGaA (Germany), Danaher Corporation (US), Promega Corporation (US), Agilent Technologies, Inc. (US), Bio-rad Laboratories, Inc. (US), illumina, inc. (US), Takara Bio Inc. (Japan), New England Biolabs (US), A&A biotechnology (Poland), Revvity, Inc. (US), Bioneer Corporation (South Korea), and HiMedia Laboratories Pvt. Ltd. (India).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com